The offer of the shares in the capital of Pharmesis International Ltd. is made in a copy of its Prospectus dated <date> and anyone wishing to acquire such shares will need to make an application in the manner set out in the Prospectus. The information in this summary is qualified in its entirety by and is subject to the more detailed information and financial statements (including the notes thereto) appearing in the Prospectus. Prospective investors should carefully consider all the information presented in the Prospectus, particularly the matters set out under "Risk Factors" before making an investment decision. |